Literature DB >> 11376849

Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells.

M Desforges1, J Charron, S Bérard, S Beausoleil, D F Stojdl, G Despars, B Laverdière, J C Bell, P J Talbot, C P Stanners, L Poliquin.   

Abstract

Acute infection of fibroblastic cell lines by the Indiana strain of vesicular stomatitis virus (VSV) usually induces dramatic cytopathic effects and shutoff of cellular gene expression. We have compared a series of independent mutants with differences in shutoff induction and found that M was mutated either in the N-terminus (M(51)R) or C-terminus (V(221)F and S(226)R). Furthermore, only double mutants (M mutation and a ts mutation related or not to M) were able to persist on fibroblast cell lines at 39 degrees C. A more detailed investigation of the infection was performed for the mutants T1026, TP3 and G31, differing in their host shutoff effects related to M protein. Viral activity in persistently infected mouse L-929 and monkey Vero cell lines was followed by viral proteins detection, RNA synthesis throughout infection and finally detection of infectious particles. All three mutants cause extensive CPE followed by emergence of persistently infected cells on Vero cells. The same thing is seen on L-929 cells except for T1026 which causes little CPE. Taken together, the results form a basis of further studies to clarify how various viral and cellular factors interact in the establishment of a persistent infection by VSV mutants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376849     DOI: 10.1016/s0168-1702(01)00251-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

1.  Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.

Authors:  Valérie Janelle; Frédérick Brassard; Pascal Lapierre; Alain Lamarre; Laurent Poliquin
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

2.  The vesicular stomatitis virus matrix protein inhibits NF-κB activation in mouse L929 cells.

Authors:  Andrew J Varble; Christopher D Ried; Warren J Hammond; Kaitlin A Marquis; Matthew C Woodruff; Maureen C Ferran
Journal:  Virology       Date:  2016-09-17       Impact factor: 3.616

3.  Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways.

Authors:  Daniel F Gaddy; Douglas S Lyles
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.

Authors:  Maryam Ahmed; Margie O McKenzie; Shelby Puckett; Michael Hojnacki; Laurent Poliquin; Douglas S Lyles
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.

Authors:  Katsunori Shinozaki; Oliver Ebert; Arief Suriawinata; Swan N Thung; Savio L C Woo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Persistent equine arteritis virus infection in HeLa cells.

Authors:  Jianqiang Zhang; Peter J Timoney; N James MacLachlan; William H McCollum; Udeni B R Balasuriya
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  The strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor control.

Authors:  Valérie Janelle; Marie-Pierre Langlois; Pascal Lapierre; Tania Charpentier; Laurent Poliquin; Alain Lamarre
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

8.  Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.

Authors:  Apollina Goel; Stephanie K Carlson; Kelly L Classic; Suzanne Greiner; Shruthi Naik; Anthony T Power; John C Bell; Stephen J Russell
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

9.  Moussa virus: a new member of the Rhabdoviridae family isolated from Culex decens mosquitoes in Côte d'Ivoire.

Authors:  Phenix-Lan Quan; Sandra Junglen; Alla Tashmukhamedova; Sean Conlan; Stephen K Hutchison; Andreas Kurth; Heinz Ellerbrok; Michael Egholm; Thomas Briese; Fabian H Leendertz; W Ian Lipkin
Journal:  Virus Res       Date:  2009-10-03       Impact factor: 3.303

10.  Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.

Authors:  Shuai Wang; Tong Dai; Ziran Qin; Ting Pan; Feng Chu; Lingfeng Lou; Long Zhang; Bing Yang; Huizhe Huang; Huasong Lu; Fangfang Zhou
Journal:  Nat Cell Biol       Date:  2021-07-08       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.